Edition:
United States

People: Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.69USD
22 Jun 2018
Change (% chg)

$-0.00 (-0.23%)
Prev Close
$0.69
Open
$0.71
Day's High
$0.71
Day's Low
$0.68
Volume
231,512
Avg. Vol
62,223
52-wk High
$1.52
52-wk Low
$0.62

Parshall, B. Lynne 

Ms. B. Lynne Parshall, J.D., is Director of Regulus Therapeutics Inc. Prior to that she was a director of Regulus Therapeutics LLC since November 2007. Ms. Parshall joined the board of directors as a representative of Isis in connection with its investment in the Company pursuant to Company's founding investor rights agreement. Ms. Parshall has served as the Chief Operating Officer of Isis since December 2007, as its Chief Financial Officer since June 1994, as its Secretary since November 1991 and as a director of Isis since September 2000. From 1986 to 1991, Ms. Parshall was a partner with Cooley LLP. From July 2005 to August 2009, Ms. Parshall served as a director of Cardiodynamics International Corporation, a publicly-held biopharmaceutical company (acquired by SonoSite, Inc. in August 2009). Ms. Parshall holds a J.D. from Stanford Law School and a B.A. in Government and Economics from Harvard University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --